Physician profile
Mark Gerard Webb
NPI 1255396867
$7,570.05
in general payments reported to CMS, 2019-2025
49 companies · $955 in 2025
The $955 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $913 · 2021: $1,342 · 2022: $1,034 · 2023: $1,340 · 2024: $1,455 · 2025: $955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,750.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,559.36 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $1,528.44 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Amgen INC. | $462.44 | 2019-2025 | Evenity, Prolia, Prolia |
| Novo Nordisk INC | $401.69 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $391.96 | 2019-2024 | Shingrix, Bexsero, Pediarix |
| Lilly USA, LLC | $298.06 | 2020-2024 | Mounjaro, Zepbound |
| Allergan, INC. | $235.62 | 2019-2020 | |
| Pfizer INC. | $224.89 | 2020-2025 | |
| Abbott Laboratories | $222.85 | 2020-2025 | Proclaim, Freestyle Libre 3, Octrode |
| Exact Sciences Corporation | $211.41 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $180.82 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $175.45 | 2019-2024 | Trintellix |
| Almatica Pharma LLC | $172.08 | 2023-2025 | Loreev Xr, Gralise, Sertraline Hcl |
| Merck Sharp & Dohme LLC | $140.40 | 2019-2021 | |
| Antares Pharma, INC. | $110.32 | 2020-2022 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.